AcSé-ESMART, a European precision cancer medicine proof-of-concept platform trial

enthalten in: Nature medicine | 2023

von Geoerger, B. | Paoletti, X. | Bautista, F. | +19

Response to comments on Jaki et al., A proposal for a new PhD level curriculum on quantitative methods for drug development. Pharm Stat 17(5):593-606, Sep/Oct 2018., DOI : https://doi.org/10.1002/pst.1873

enthalten in: Pharmaceutical statistics | 2019

von Jaki, T. | Gordon, A. | Forster, P. | +13

Precision medicine : lessons learned from the SHIVA trial - Authors' reply

enthalten in: The Lancet. Oncology | 2015

von Le Tourneau, C. | Belin, L. | Paoletti, X. | +2

Critical evaluation of disease stabilization as a measure of activity of systemic therapy : lessons from trials with arms in which patients do not receive active treatment

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2014

von Le Tourneau, C. | Paoletti, X. | Coquan, E. | +3

Sensitivity analysis when data are missing not-at-random

enthalten in: Epidemiology (Cambridge, Mass.) | 2011

von Resseguier, N. | Giorgi, R. | Paoletti, X.

Treatment outcomes for hepatocellular carcinoma using chemoembolization in combination with other therapies

enthalten in: Cancer treatment reviews | 2007

von Tournoux, C. | Paoletti, X. | Barbare, J.